Prevalence of oral human papillomavirus infection among university students in Valencia, Spain

Vaccine. 2019 Oct 8;37(43):6276-6281. doi: 10.1016/j.vaccine.2019.08.058. Epub 2019 Sep 9.

Abstract

Human papillomavirus (HPV) infection contributes to the pathogenesis of oropharyngeal squamous cell carcinomas. We estimated prevalence and six-month persistence of oral HPV infections among university students ages 18-25 years living in Valencia, Spain, during the 2012-2013 academic year. Participants provided oral rinse samples; HPV-positive subjects provided a follow-up sample. The study included 543 students; 70 (12.9%) women had received HPV vaccination. Prevalence among vaccinees and non-vaccinees were 10.0% (95% CI: 4.1-19.5%) and 6.8% (95% CI: 4.7-9.4%), respectively. All HPV infections among vaccinees were non-typeable genotypes; 59.4% of non-vaccinees had high-risk genotype infections. Follow-up samples were obtained from 36 participants; one vaccinee (whose specimen was non-typeable) and seven non-vaccinees were found to be HPV positive. Among non-vaccinees, six-month persistence was 10.3% (95% CI: 2.2-27.4%); all persistent infections were with high-risk genotypes. Our results, although subject to study limitations, may support the need to implement new public health strategies.

Keywords: Clearance; Oral human papillomavirus; Oropharynx; Persistence; Prevalence; Young adult.

MeSH terms

  • Adolescent
  • Adult
  • DNA, Viral / genetics
  • Female
  • Genotype
  • Human papillomavirus 16
  • Humans
  • Male
  • Mouth / virology*
  • Mouth Diseases / epidemiology*
  • Mouth Diseases / virology*
  • Oropharyngeal Neoplasms / epidemiology
  • Oropharyngeal Neoplasms / virology
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / virology*
  • Papillomavirus Vaccines / administration & dosage
  • Prevalence
  • Spain / epidemiology
  • Students / statistics & numerical data*
  • Universities
  • Vaccination / statistics & numerical data
  • Young Adult

Substances

  • DNA, Viral
  • Papillomavirus Vaccines